Results 201 to 210 of about 779,655 (355)
A New Korean Nomenclature for Steatotic Liver Disease [PDF]
Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
doaj +2 more sources
Fatty liver reexamined choline and mitochondrial toxin amelioration. [PDF]
Mercola J.
europepmc +1 more source
Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs
Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner +8 more
wiley +1 more source
Acute Fatty Liver in Pregnancy: Literature Review. [PDF]
Zarni S, Viegas A.
europepmc +1 more source
Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
This review explores how 3D bioprinting drives innovation in developing in vitro skin models that mimic immune‐mediated diseases. It highlights current technologies, key applications in studying skin pathologies, and emerging challenges. The review points toward future opportunities for improving disease modeling and advancing therapeutic and cosmetic ...
Andrea Ulloa‐Fernández +4 more
wiley +1 more source
Association of non-alcoholic fatty liver polygenic risk scores with the incident and progressive non-alcoholic fatty liver disease in Chinese population. [PDF]
Zhou Y +11 more
europepmc +1 more source
Hybrid Scaffolds Decouple Biochemical & Biophysical Regulation of Cell Phenotype
Replicating tissue‐specific extracellular matrix is crucial for understanding its role in disease. This work demonstrates independent control over stiffness, composition and 3D collagen architecture using hybrid scaffolds: patterned collagen perfused with defined hydrogels.
Xinyuan Song +17 more
wiley +1 more source
Machine learning to predict metabolic-associated fatty liver disease. [PDF]
Cicerone O, Maestri M.
europepmc +1 more source

